Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 42Terminated 10Unknown 3Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 3Immunoblastic Lymphadenopathy 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Hodgkin Disease 2Sezary Syndrome 1Recurrence 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Bronchiolitis Obliterans Syndrome 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 18Rituximab 10fludarabine 8ibrutinib 6fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Radiotherapy 4Mycophenolic Acid 4Melphalan 4Filgrastim 4Cyclosporine 4Chlorambucil 4Antilymphocyte Serum 4Antigens, CD19 4Valproic Acid 3Sensitivity and Specificity 3Indium 3Immunotherapy, Adoptive 3Busulfan 3Alemtuzumab 3venetoclax 2sargramostim 2obinutuzumab 2navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 2epratuzumab 2Tacrolimus 2Radioimmunodetection 2Psychiatric Rehabilitation 2Pentostatin 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Leukemia, Lymphocytic, Chronic, B-Cell × Alemtuzumab × Clear all
NCT00337519 2009-01-29

Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia

Charite University, Berlin, Germany

Phase 2 Unknown
82 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00800943 2008-12-03

CRC005

Chronic Lymphocytic Leukemia Research Consortium

Phase 2 Unknown
31 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00336206 2006-07-25

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Tawam Hospital

Phase NA Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡